• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天疱疮的辅助治疗

Adjuvant therapy of pemphigus.

作者信息

Bystryn J C

出版信息

Arch Dermatol. 1984 Jul;120(7):941-51.

PMID:6375579
Abstract

The effectiveness of adjuvant therapy of pemphigus was evaluated by comparing the results of studies of pemphigus treated with corticosteroids and adjuvant as opposed to corticosteroids only. There has been a steady and striking improvement in the prognosis of pemphigus during the past three decades. However, factors other than the use of adjuvant therapy appear to be responsible, since the survival and incidence of remissions in patients treated with adjuvants was only slightly better than that of patients treated with corticosteroids alone. The variable course of pemphigus and the lack of stratification makes it difficult to judge whether these slight differences have any relevance. A suggested protocol to treat pemphigus is presented.

摘要

通过比较使用皮质类固醇和辅助药物治疗天疱疮与仅使用皮质类固醇治疗天疱疮的研究结果,评估了天疱疮辅助治疗的有效性。在过去三十年中,天疱疮的预后有了稳步且显著的改善。然而,似乎是其他因素而非辅助治疗的使用起了作用,因为接受辅助治疗的患者的生存率和缓解率仅略高于仅接受皮质类固醇治疗的患者。天疱疮病程多变且缺乏分层,这使得判断这些细微差异是否有意义变得困难。本文提出了一个治疗天疱疮的建议方案。

相似文献

1
Adjuvant therapy of pemphigus.天疱疮的辅助治疗
Arch Dermatol. 1984 Jul;120(7):941-51.
2
The adjuvant therapy of pemphigus. An update.天疱疮的辅助治疗。最新进展。
Arch Dermatol. 1996 Feb;132(2):203-12.
3
Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies.血浆置换疗法对天疱疮抗体循环水平的影响。
J Am Acad Dermatol. 1990 Jan;22(1):35-40. doi: 10.1016/0190-9622(90)70004-2.
4
[Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].[环磷酰胺每周脉冲疗法联合皮质类固醇治疗天疱疮]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001 Apr;23(2):173-5.
5
[Therapy of pemphigus. Critical remarks based on 44 clinical cases].[天疱疮的治疗。基于44例临床病例的批判性评论]
Hautarzt. 1985 Feb;36(2):96-102.
6
Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.天疱疮的十二年临床治疗经验:54例回顾性研究
Int J Dermatol. 2005 Oct;44(10):821-7. doi: 10.1111/j.1365-4632.2005.02218.x.
7
[Course and results of combined treatment of pemphigus with corticosteroids and imuran].[天疱疮的皮质类固醇与硫唑嘌呤联合治疗的过程及结果]
Przegl Dermatol. 1974 Jul-Aug;61(4):503-7.
8
[Comparative evaluation of the treatment of pemphigus with corticosteroids and corticosteroids combined with immunosuppressive agents].[糖皮质激素及糖皮质激素联合免疫抑制剂治疗天疱疮的对比评估]
Przegl Dermatol. 1981 Mar-Apr;68(2):227-32.
9
[Herpetic superinfection of pemphigus: 6 cases].[天疱疮的疱疹病毒重叠感染:6例]
Ann Dermatol Venereol. 1999 Oct;126(10):699-702.
10
Fate of pemphigus antibody following successful therapy. Preliminary evaluation of pemphigus antibody determinations to regulate therapy.成功治疗后天疱疮抗体的转归。天疱疮抗体测定用于指导治疗的初步评估。
Arch Dermatol. 1978 Dec;114(12):1769-72.

引用本文的文献

1
Rituximab Therapy for Treatment of Pemphigus in Southeast Asians.利妥昔单抗治疗东南亚天疱疮。
Drug Des Devel Ther. 2021 Apr 22;15:1677-1690. doi: 10.2147/DDDT.S306046. eCollection 2021.
2
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.利妥昔单抗对寻常型天疱疮患者是一种有效的治疗方法,并具有激素节省作用。
Br J Dermatol. 2020 May;182(5):1111-1119. doi: 10.1111/bjd.18482. Epub 2019 Nov 28.
3
Correlation between polymorphisms of the NR3C1 gene and glucocorticoid effectiveness in patients with pemphigus vulgaris.
寻常型天疱疮患者 NR3C1 基因多态性与糖皮质激素疗效的相关性。
Sci Rep. 2017 Sep 19;7(1):11890. doi: 10.1038/s41598-017-12255-0.
4
Beneficial effects and safety of corticosteroids combined with traditional chinese medicine for pemphigus: a systematic review.糖皮质激素联合中药治疗天疱疮的疗效及安全性:系统评价。
Evid Based Complement Alternat Med. 2015;2015:815358. doi: 10.1155/2015/815358. Epub 2015 Feb 22.
5
Pemphigus vulgaris: an evidence-based treatment update.寻常型天疱疮:基于证据的治疗更新。
Drugs. 2015 Feb;75(3):271-84. doi: 10.1007/s40265-015-0353-6.
6
Vesiculo-bullous disorders in adulthood.成人水疱性疾病。
Can Fam Physician. 1987 Dec;33:2797-800.
7
Novel therapies for pemphigus vulgaris: an overview.寻常型天疱疮的新型治疗方法:概述。
Drugs Aging. 2009;26(10):833-46. doi: 10.2165/11316810-000000000-00000.
8
Therapy of autoimmune bullous diseases.自身免疫性大疱性疾病的治疗。
Ther Clin Risk Manag. 2007 Mar;3(1):29-40. doi: 10.2147/tcrm.2007.3.1.29.
9
Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.氨苯砜作为寻常型天疱疮维持期糖皮质激素节省剂的多中心随机、双盲、安慰剂对照临床试验。
Arch Dermatol. 2008 Jan;144(1):25-32. doi: 10.1001/archderm.144.1.25.
10
What's new in blistering disorders?水疱性疾病有哪些新进展?
Curr Allergy Asthma Rep. 2007 Jul;7(4):255-63. doi: 10.1007/s11882-007-0038-7.